HRSA finalizes 340B rebate pilot roster ahead of 2027 launch
HRSA identified 10 drugmakers and 21 drugs for its revised 340B rebate pilot, reviving debate over oversight, costs and provider access.
Article label: Quick Read
Premium article
The Health Resources and Services Administration (HRSA) has named 10 pharmaceutical manufacturers and 21 drugs that will participate in its revised 340B Rebate Model Pilot Program, scheduled to begin January 1, 2027.
HRSA published the participant list on October 2, providing details on a program that will replace traditional upfront
